Trial Profile
Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary) ; Prednisolone
- Indications Drug hypersensitivity
- Focus Therapeutic Use
- Acronyms COLAR
- 18 Apr 2020 Status changed from recruiting to completed.
- 11 Feb 2019 Planned End Date changed from 1 May 2020 to 1 Jun 2020.
- 11 Feb 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Jan 2020.